Also known as آسٹیوپوروسس مینجمنٹ
Diabetologist
M.B.B.S, MRCP (UK), MRCP (London), Specialty Certificate in Endocrinology and Diabetes
Diabetologist
M.B.B.S, MRCP (UK), MRCP (London), Specialty Certificate in Endocrinology and Diabetes
Internal Medicine Specialist
MBBS, MRCP (UK)
Consultant Physician
F.C.P.S, M.C.P.S, M.B.B.S
Consultant Physician
MBBS, DFM (Family Medicine), MCPS (Family Medicine), MRCGP (International), Diploma in Diabetes
Consultant Physician
MBBS, DFM (Family Medicine), MCPS (Family Medicine), MRCGP (International), Diploma in Diabetes
Endocrinologist
MBBS, Diploma in Diabetology, MSc (Diabetes & Endocrinology)
Endocrinologist
MBBS, Diploma in Diabetology, MSc (Diabetes & Endocrinology)
Internal Medicine Specialist
M.B.B.S, F.C.P.S (Medicine), F.C.P.S (Endocrinology Diabetes and Metabolism)
Internal Medicine Specialist
M.B.B.S, F.C.P.S (Medicine), F.C.P.S (Endocrinology Diabetes and Metabolism)
Internal Medicine Specialist
M.B.B.S, F.C.P.S. (Medicine)
Internal Medicine Specialist
MBBS, FCPS (Medicine)
Internal Medicine Specialist
M.B.B.S. , F.C.P.S. (Internal Medicine Specialist)
Bisphosphonates are used as first-line pharmacologictreatment for osteoporosis. In patients who cannot tolerate or whose symptoms do not improve with bisphosphonate therapy, teriparatide (Forteo) and denosumab (Prolia) are effective alternative medications to prevent osteoporotic fractures